229 related articles for article (PubMed ID: 28677503)
1. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
Wang Q; Imam MU; Yida Z; Wang F
Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
[TBL] [Abstract][Full Text] [Related]
2. Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study.
Gangadhariah M; Pardhi T; Ravilla J; Chandra S; Singh SA
J Biomol Struct Dyn; 2023; 41(21):11373-11393. PubMed ID: 36576222
[TBL] [Abstract][Full Text] [Related]
3. The role of peroxisome proliferator-activated receptor gamma in prostate cancer.
Elix C; Pal SK; Jones JO
Asian J Androl; 2018; 20(3):238-243. PubMed ID: 28597850
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Nelumbinis folium targeting PPARγ for weight management: A molecular docking and molecular dynamics simulations study.
Wong AR; Yang AWH; Gill H; Lenon GB; Hung A
Comput Biol Med; 2023 Nov; 166():107495. PubMed ID: 37742414
[TBL] [Abstract][Full Text] [Related]
5. The role of PPARγ in prostate cancer development and progression.
Hartley A; Ahmad I
Br J Cancer; 2023 Apr; 128(6):940-945. PubMed ID: 36510001
[TBL] [Abstract][Full Text] [Related]
6. PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges.
Zhang J; Tang M; Shang J
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397426
[TBL] [Abstract][Full Text] [Related]
7. The Role of PPARgamma in pulmonary vascular disease.
Hart CM
J Investig Med; 2008 Feb; 56(2):518-21. PubMed ID: 18317434
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma physiology and pathology in gastrointestinal epithelial cells.
Thompson EA
Mol Cells; 2007 Oct; 24(2):167-76. PubMed ID: 17978568
[TBL] [Abstract][Full Text] [Related]
9. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARγ.
Yu Y; Farooq MS; Eberhart Meessen S; Jiang Y; Kato D; Zhan T; Weiss C; Seger R; Kang W; Zhang X; Yu J; Ebert MPA; Burgermeister E
Cell Death Dis; 2024 Jan; 15(1):7. PubMed ID: 38177114
[TBL] [Abstract][Full Text] [Related]
10. PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs.
Luan J; Ji X; Liu L
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833942
[TBL] [Abstract][Full Text] [Related]
11. PPAR Agonists and Cardiovascular Disease in Diabetes.
Calkin AC; Thomas MC
PPAR Res; 2008; 2008():245410. PubMed ID: 18288280
[TBL] [Abstract][Full Text] [Related]
12. Obesity alters pathology and treatment response in inflammatory disease.
Bapat SP; Whitty C; Mowery CT; Liang Y; Yoo A; Jiang Z; Peters MC; Zhang LJ; Vogel I; Zhou C; Nguyen VQ; Li Z; Chang C; Zhu WS; Hastie AT; He H; Ren X; Qiu W; Gayer SG; Liu C; Choi EJ; Fassett M; Cohen JN; Sturgill JL; Crotty Alexander LE; Suh JM; Liddle C; Atkins AR; Yu RT; Downes M; Liu S; Nikolajczyk BS; Lee IK; Guttman-Yassky E; Ansel KM; Woodruff PG; Fahy JV; Sheppard D; Gallo RL; Ye CJ; Evans RM; Zheng Y; Marson A
Nature; 2022 Apr; 604(7905):337-342. PubMed ID: 35355021
[TBL] [Abstract][Full Text] [Related]
13. New Insights into the Role of PPARγ in Skin Physiopathology.
Briganti S; Mosca S; Di Nardo A; Flori E; Ottaviani M
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927131
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes.
Schnegg CI; Robbins ME
PPAR Res; 2011; 2011():373560. PubMed ID: 22135673
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists
Orsi DL; Pook E; Bräuer N; Friberg A; Lienau P; Lemke CT; Stellfeld T; Brüggemeier U; Pütter V; Meyer H; Baco M; Tang S; Cherniack AD; Westlake L; Bender SA; Kocak M; Strathdee CA; Meyerson M; Eis K; Goldstein JT
J Med Chem; 2022 Nov; 65(21):14843-14863. PubMed ID: 36270630
[TBL] [Abstract][Full Text] [Related]
16. Unveiling clinically significant PPARγ mutations for thiazolidinedione treatment responsiveness through atomistic simulations.
Shahrear S; Islam ABMMK
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126990. PubMed ID: 37741483
[TBL] [Abstract][Full Text] [Related]
17. The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.
Tsukahara T
PPAR Res; 2012; 2012():362361. PubMed ID: 22693486
[TBL] [Abstract][Full Text] [Related]
18. PPAR gamma, bioactive lipids, and cancer progression.
Robbins GT; Nie D
Front Biosci (Landmark Ed); 2012 Jan; 17(5):1816-34. PubMed ID: 22201838
[TBL] [Abstract][Full Text] [Related]
19. Potential Antidiabetic Activity of β-sitosterol from Zingiber roseum Rosc. via Modulation of Peroxisome Proliferator-activated Receptor Gamma (PPARγ).
Amanat M; Daula AFMSU; Singh R
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38305397
[TBL] [Abstract][Full Text] [Related]
20. Advances in Studies of Chiglitazar Sodium, a Novel PPAR Pan-Agonist, for the Treatment of Type 2 Diabetes Mellitus.
Zhang XH; Tian YF; Huang GL; Cui WY; Sun Q; He WJ; Liu XJ
Curr Med Sci; 2023 Oct; 43(5):890-896. PubMed ID: 37326885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
